Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > FGFR > Infigratinib (Synonyms: BGJ-398; NVP-BGJ398)

Infigratinib | BGJ-398 | NVP-BGJ398

ChemLeader 98+%

Catalog No：CL1547 CAS No.：872511-34-7 MDLNo： Formula：C26H31Cl2N7O3 MW：560.48

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
5 mg	3-5days	￥288.00	Visible after login	- +
10 mg	3-5days	￥488.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Infigratinib (Synonyms: BGJ-398; NVP-BGJ398)
CAS	872511-34-7
Formula	C26H31Cl2N7O3
MW	560.48
Appearance	White to yellow powder
Storage condition	Store in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃.

Product details

Infigratinib (BGJ-398; NVP-BGJ398) is a potent inhibitor of the FGFR family with IC₅₀s of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively.
Tags: buy Infigratinib (BGJ398) | Infigratinib (BGJ398) supplier | purchase Infigratinib (BGJ398) | Infigratinib (BGJ398) cost | Infigratinib (BGJ398) manufacturer | order Infigratinib (BGJ398) | Infigratinib (BGJ398) distributor

Related literature

Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-me thyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor T

PMID: 21936542 DOI: 10.1021/jm2006222

Read more

Identifying and Targeting Sporadic Oncogenic Genetic Aberrations in Mouse Models of Triple Negative Breast Cancer.

PMID: 29203461 PMCID: PMC5907916 DOI: 10.1158/2159-8290.CD-17-0679

Read more

Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.

PMID: 23443805 DOI: 10.1158/1535-7163.MCT-12-0999

Read more

Related

Sorry, no related items

History

Infigratinib (Synonyms: BGJ-398; NVP-BGJ398)

872511-34-7 98+%

LDN193189 (Synonyms: DM-3189)

1062368-24-4 98+%

Olokizumab (Anti-IL-6 / IFNb2)

1007223-17-7 95+%

Ixekizumab (Anti-CTLA-8 / IL-17a)

1143503-69-8 95+%

1314238-96-4 95+%

55779-48-1 98+%

Poseltinib | HM71224 | LY3337641

1353552-97-2 98+%

L-Tetrahydropalmatine | Rotundine | (-)-Tetrahydropalmatine

Timosaponin A3 | Timosaponin AIII

41059-79-4 98+%